Investors are increasingly worried that
Estimates of Chemours’ liabilities related to the chemicals, known as per- and polyfluoroalkyl substances, or PFAS, range from the company’s figure of up to $802 million, to one analyst’s calculation of more than $160 billion—more than 15 times the company’s highest-ever market capitalization.
Investors, regulators, and the public will get a better sense Nov. 4 of how big Chemours thinks its problems are, when the company releases ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.